Dr Hemanta Koley

About

After completion of his master degree in Physiology from University College of Science & Technology, Calcutta University, he joined in National institute of Cholera and Enteric Diseases, Beliaghata, Calcutta for his Ph. D. degree under super guidance of Dr. G.Balakrish Nair, PhD, FNA, FNASc, FTWAS, FAAM. In 1996, he joined as Associate Professor in Dept. Physiology, College of Medical Sciences-Nepal, where he devoted entire heartily in teaching medical students till 2000.

In the meantime Dr. Koley got opportunity for Post-Doctoral research under Dr Dipak Sarkar, at Dept of Physiology, Rutgers -The State University of New Jersey, New Brunswick, USA.

After completion of one year in Rutgers University, Dr. Koley moved to Boston, joined in VA Health Care , Harvard Medical School as Research Associate and worked there on “Molecular mechanism of Barrett’s esophagus and to work on Adenocarcinoma” under leadership of Prof. R K Goyal, Mallinckrodt Professor of Medicine, renowned gastroenterologist

Employment

• Scientist- F / Deputy Director Division of Bacteriology ICMR-National Institute of Cholera and Enteric Diseases P-33, C.I.T. Road, Scheme XM, Beliaghata, Kolkata-700010. Email: [email protected]; [email protected], Cell +91 9831031307 Scientist -F / Deputy Director
  2004 - Present

Education

• University of Calcutta University College of Science Technology and Agriculture MSc

Projects & Funding

Projects & funding information is unavailable.

Publications (112)

• Antimicrobial Resistance in Salmonella from Indian Poultry: Trends, Challenges, and One Health Perspectives
  Journal of Pure and Applied Microbiology 2026 DOI: 10.22207/JPAM.20.1.31
  +Save
• A prophylactic study of curcumin nanoparticle-induced bacterial ghosts against Helicobacter pylori in a C57BL/6 mouse model
  Microbial Pathogenesis 2025 DOI: 10.1016/j.micpath.2025.108084
  +Save
• Establishment of an intragastric surgical model using C57BL/6 mice to study the vaccine efficacy of OMV-based immunogens against Helicobacter pylori
  Biology Open 2025 DOI: 10.1242/bio.060282
  +Save
• Extracellular Vesicles and Bacterial Infection
  2024 DOI: 10.1007/978-981-97-2494-9_5
  +Save
• Establishment of an intragastric surgical model using C57BL/6 mice to study the vaccine efficacy of OMV-based immunogens againstHelicobacter pylori
  2023 DOI: 10.1101/2023.11.16.567319
  +Save
• Bacterial ghost cell based bivalent candidate vaccine against Salmonella Typhi and Salmonella Paratyphi A: A prophylactic study in BALB/c mice
  Vaccine 2023 DOI: 10.1016/j.vaccine.2023.08.049
  +Save
• Cloning, improved expression and purification of invasion plasmid antigen D (IpaD): an effector protein of enteroinvasive Escherichia coli (EIEC).
  Biotechnology & genetic engineering reviews 2023 DOI: 10.1080/02648725.2023.2184027
  +Save
• A tetravalent Shigella Outer Membrane Vesicles based candidate vaccine offered cross-protection against all the serogroups of Shigella in adult mice.
  Microbes and infection 2023 DOI: 10.1016/j.micinf.2023.105100
  +Save
• Facile synthesis of multi-faceted, biomimetic and cross-protective nanoparticle-based vaccines for drug-resistant Shigella: a flexible platform technology
  Journal of Nanobiotechnology 2023 DOI: 10.1186/s12951-023-01780-y
  +Save
• Genomic insights into extensively drug-resistant Pseudomonas aeruginosa isolated from a diarrhea case in Kolkata, India
  Future Microbiology 2023 DOI: 10.2217/fmb-2022-0140
  +Save